Federal biological data platform opens to researchers—with industry influence and geopolitical gatek

What it does

This bill directs the Department of Energy to award a grant to a National Laboratory to build a centralized online platform—the 'Web of Biological Data'—that aggregates biological research data funded by the federal government and makes it accessible to researchers via a single entry point. The platform will use artificial intelligence and advanced computational tools to help scientists discover and analyze biological datasets, with tiered security controls and restrictions on sharing data with certain countries.

Why we flagged it

The bill establishes a federally funded, centralized data platform to consolidate and share biological research data across government agencies and with academic and industry partners. Its core function is infrastructure development for scientific research, not regulation, appropriation, or commemoration.

What the text implies

• The bill grants the Secretary of Energy broad discretion to determine which countries are excluded from data sharing ('adversarial countries and countries that do not participate in reciprocal data sharing'), creating potential for geopolitical data gatekeeping without explicit congressional criteria.
• Industry cost-sharing agreements and partnerships may create financial incentives for private companies to influence data curation, access policies, or research priorities, potentially biasing the platform toward commercially valuable datasets.
• The FACA exemption for the advisory board removes standard transparency and conflict-of-interest requirements, allowing industry representatives (4 of 11 members) to advise on data governance without public disclosure of their interests.
• The bill does not specify ownership or licensing terms for data hosted on the platform, creating ambiguity about whether private companies can claim intellectual property rights over federally funded biological data.
• Tiered access controls and cybersecurity safeguards are described in general terms; the actual implementation plan is deferred to the Director, potentially allowing restrictive access policies that undermine the stated goal of broad researcher access.

Who it affects

The bill creates a public research infrastructure that consolidates federally funded biological data into one accessible platform, reducing duplication and accelerating scientific discovery that may benefit public health and medicine. The rule-of-construction clause explicitly preserves privacy and informed-consent protections, limiting the risk of misuse.

Who stands to gain

• biotechnology companies
• pharmaceutical firms
• AI/machine learning vendors
• cloud infrastructure providers
• the selected National Laboratory

Named in the bill

Department of Energy (DOE), National Laboratory, National Institute of Standards and Technology (NIST), National Science Foundation (NSF), National Library of Medicine, National Center for Biotechnology Information (NCBI), Senate Committee on Energy and Natural Resources, House Committee on Science, Space, and Technology

Where it stands

3 cosponsors: 2 Democrats, 1 Republicans.

• Jun 11, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Jun 11, 2026 — Referred to Senate Committee on Energy and Natural Resources · Congress.gov: “Read twice and referred to the Committee on Energy and Natural Resources”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.